PharmTech: DCAT Week 2025: Impact of Geopolitical Climate on Biopharma

Published on March 19, 2025

Uncertainty in the global climate is reshaping the bio/pharma industry’s supply chain strategies. In a recent interview with PharmTech, Joseph Principe, Chief Commercial Officer at Abzena, discusses how legislative factors such as the BIOSECURE Act and potential tariffs are driving new approaches to ensure continuity of supply. Abzena will be exploring these topics further at DCAT Week 2025, March 17–20 in New York City.

Watch the full interview here

The post PharmTech: DCAT Week 2025: Impact of Geopolitical Climate on Biopharma appeared first on Abzena.

Continue reading on website
Other news

Norstella named to Fast Company’s annual list of the world’s most innovative companies of 2025

March 18, 2025
New York – March 18, 2025 – Norstella, a leading global provider of pharma intelligence solutions, is proud to have been named to Fast Company’s prestigious list of the World’s Most Innovative Companies of 2025. This year’s list shines a spotlight on businesses that are shaping industry and culture through their innovations to set new standards and achieve remarkable milestones in all sectors of t

Abzena Wins Champion Award at the 2025 CDMO Leadership Awards

March 21, 2025
Abzena took home the ‘Champion Award’ in the Biologics- Global category at the 2025 CDMO Leadership Awards ceremony on March 19th in NYC.  Beating out 17 other CDMOs for the top spot, Abzena’s SVP of Global Marketing, Kimberly Burrell, accepted the award stating, “We are a team based in the UK and the US, and we all come together to support our clients’ needs with the highest standards of quality